{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Coriander sativum", "EGFR", "Lung cancer", "O. tenuiflorum", "in silico.", "in vitro"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37653637", "DateCompleted": {"Year": "2024", "Month": "05", "Day": "28"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "28"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1573409920666230831144716"], "Journal": {"ISSN": "1875-6697", "JournalIssue": {"Volume": "20", "Issue": "5", "PubDate": {"Year": "2024"}}, "Title": "Current computer-aided drug design", "ISOAbbreviation": "Curr Comput Aided Drug Des"}, "ArticleTitle": "Chemical Composition, <i>In vitro</i> and <i>In silico</i> Evaluation of Essential Oil from <i>Ocimum tenuiflorum</i> and <i>Coriandrum sativum</i> Linn for Lung Cancer.", "Pagination": {"StartPage": "628", "EndPage": "639", "MedlinePgn": "628-639"}, "Abstract": {"AbstractText": ["Medicinal plants play an essential role in everyday life; plants highly contain therapeutic phytoconstituents commonly used to treat various diseases. This paper discusses the Chemical composition, <i>In vitro</i> antiproliferative activity and <i>In silico</i> study of essential oil extracted from <i>Ocimum tenuiflorum</i> (family Lamiaceae) and <i>Coriandrum sativum</i> (family Apiaceae).", "In present study GC-MS was used to identify the chemical constituents from <i>O. tenuiflorum</i> and <i>C. sativum</i>. <i>In vitro</i> antiproliferative activity was performed on A549 cancer cell lines. <i>In silico</i> study was performed by Schrodinger's maestro software to identify chemical constituents in both plants as potential EGFR inhibitors for the treatment of lung cancer.", "The essential oil was extracted by hydro distillation from aerial parts of <i>O. tenuiflorum</i> and <i>C. sativum</i>. The volatile oil sample was analyzed by (GC-MS) Gas Chromatography- Mass Spectrometry. Different chemical constituents were identified based on the retention index and compared with the NIST library. The oil samples from <i>O. tenuiflorum</i> and <i>C. sativum</i> was also evaluated for antiproliferative activity against human lung cancer A549 cell lines. In silico study was performed by Schrodinger maestro software against EGFR (PDB ID 5HG8).", "<i>O. tenuiflorum</i> essential oil contains Eugenol (42.90%), 2-\u03b2-Elemene (25.98%), \u03b2- Caryophyllene (19.12%) are the major constituents. On the other side, <i>C. sativum</i> contains nnonadecanol- 1 (16.37%), decanal (12.37%), dodecanal (12.27%), 2-Dodecanal (9.67%), Phytol (8.81%) as the major constituents. Both the oils have shown <i>in vitro</i> antiproliferative activity against human lung cancer cell lines A549 having IC<sub>50</sub> values of 38.281 \u03bcg/ml (<i>O. tenuiflorum</i>) and 74.536 \u03bcg/ml (<i>C. sativum</i>). Molecular interactions of constituents hydro distilled from two oils was analysed by schrodinger maestro software against EGFR (PDB ID 5HG8).", "The oil sample extracted from <i>O. tenuiflorum</i> showed more antiproliferative activity than <i>C. sativum</i>. <i>In silico</i> study showed that two chemical constituents, namely di-isobutyl phthalate (-7.542 kcal/mol) and dibutyl phthalate (-7.181 kcal/mol) from <i>O. tenuiflorum</i> and one diethyl phthalate (-7.224 kcal/mol) from <i>C. sativum</i> having more docking score than standard Osimertinib which indicates the effectiveness of oils for lung cancer."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Product Chemistry Laboratory, Department of Pharmaceutical Sciences & Natural Products, Central University of Punjab, Ghudda, Bathinda, Punjab, 151401, India."}], "LastName": "Singh", "ForeName": "Bhim", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Signaling and Drug Discovery Laboratory, Department of Biochemistry, Central University of Punjab, Bathinda, Punjab, 151401, India."}], "LastName": "Prajapati", "ForeName": "Kumari Sunita", "Initials": "KS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Product Chemistry Laboratory, Department of Pharmaceutical Sciences & Natural Products, Central University of Punjab, Ghudda, Bathinda, Punjab, 151401, India."}], "LastName": "Kumar", "ForeName": "Amit", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Product Chemistry Laboratory, Department of Pharmaceutical Sciences & Natural Products, Central University of Punjab, Ghudda, Bathinda, Punjab, 151401, India."}], "LastName": "Patel", "ForeName": "Shivam", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Signaling and Drug Discovery Laboratory, Department of Biochemistry, Central University of Punjab, Bathinda, Punjab, 151401, India."}], "LastName": "Kumar", "ForeName": "Shashank", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Product Chemistry Laboratory, Department of Pharmaceutical Sciences & Natural Products, Central University of Punjab, Ghudda, Bathinda, Punjab, 151401, India."}], "LastName": "Jaitak", "ForeName": "Vikas", "Initials": "V"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Comput Aided Drug Des", "NlmUniqueID": "101265750", "ISSNLinking": "1573-4099"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Oils, Volatile"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "ErbB Receptors"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "chemistry", "isolation & purification"], "DescriptorName": "Oils, Volatile"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": [], "DescriptorName": "A549 Cells"}, {"QualifierName": ["chemistry"], "DescriptorName": "Coriandrum"}, {"QualifierName": ["pharmacology", "chemistry", "isolation & purification"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ocimum"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Gas Chromatography-Mass Spectrometry"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "ErbB Receptors"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Xia C.; Dong X.; Li H.; Cao M.; Sun D.; He S.; Yang F.; Yan X.; Zhang S.; Li N.; Chen W.; Cancer statistics in China and United States, 2022: Profiles, trends, and determinants. Chin Med J 2022,135(5),584-590", "ArticleIdList": ["10.1097/CM9.0000000000002108", "35143424"]}, {"Citation": "Deo S.V.S.; Sharma J.; Kumar S.; GLOBOCAN 2020 report on global cancer burden: Challenges and opportunities for surgical oncologists. Ann Surg Oncol 2022,29(11),6497-6500", "ArticleIdList": ["10.1245/s10434-022-12151-6", "35838905"]}, {"Citation": "Pradhan K.S.; Chawla P.; Tiwari R.; HRDEL: High ranking deep ensemble learning-based lung cancer diagnosis model. Expert Syst Appl 2023,213,118956", "ArticleIdList": ["10.1016/j.eswa.2022.118956"]}, {"Citation": "Sharma P.; Mehta M.; Dhanjal D.S.; Kaur S.; Gupta G.; Singh H.; Thangavelu L.; Rajeshkumar S.; Tambuwala M.; Bakshi H.A.; Chellappan D.K.; Dua K.; Satija S.; Emerging trends in the novel drug delivery approaches for the treatment of lung cancer. Chem Biol Interact 2019,309,108720", "ArticleIdList": ["10.1016/j.cbi.2019.06.033", "31226287"]}, {"Citation": "Chen L.; Fu W.; Zheng L.; Liu Z.; Liang G.; Recent progress of small-molecule epidermal growth factor receptor (EGFR) inhibitors against C797S resistance in non-small-cell lung cancer: Miniperspective J Med Chem 2018,61(10),4290-4300", "ArticleIdList": ["10.1021/acs.jmedchem.7b01310", "29136465"]}, {"Citation": "Tian X.; Gu T.; Lee M.H.; Dong Z.; Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer. Biochim Biophys Acta Rev Cancer 2022,1877(1),188645", "ArticleIdList": ["10.1016/j.bbcan.2021.188645", "34793897"]}, {"Citation": "Cao S.Y.; Li Y.; Meng X.; Zhao C.N.; Li S.; Gan R.Y.; Li H.B.; Dietary natural products and lung cancer: Effects and mechanisms of action. J Funct Foods 2019,52,316-331", "ArticleIdList": ["10.1016/j.jff.2018.11.004"]}, {"Citation": "Hoy H.; Lynch T.; Beck M.; Surgical treatment of lung cancer. Crit Care Nurs Clin North Am 2019,31(3),303-313", "ArticleIdList": ["31351552"]}, {"Citation": "Eltayeb K.; La Monica S.; Tiseo M.; Alfieri R.; Fumarola C.; Reprogramming of lipid metabolism in lung cancer: An overview with focus on EGFR-Mutated non-small cell lung cancer. Cells 2022,11(3),413", "ArticleIdList": ["10.3390/cells11030413", "35159223"]}, {"Citation": "Leonetti A.; Sharma S.; Minari R.; Perego P.; Giovannetti E.; Tiseo M.; Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. Br J Cancer 2019,121(9),725-737", "ArticleIdList": ["10.1038/s41416-019-0573-8", "31564718"]}, {"Citation": "Skribek M.; Rounis K.; Tsakonas G.; Ekman S.; Complications following novel therapies for non\u2010small cell lung cancer. J Intern Med 2022,291(6),732-754", "ArticleIdList": ["10.1111/joim.13445", "35032058"]}, {"Citation": "Alam M.; Alam S.; Shamsi A.; Adnan M.; Elasbali A.M.; Al-Soud W.A.; Alreshidi M.; Hawsawi Y.M.; Tippana A.; Pasupuleti V.R.; Hassan M.I.; Bax/Bcl-2 cascade is regulated by the EGFR pathway: Therapeutic targeting of non-small cell lung cancer. Front Oncol 2022,12,869672", "ArticleIdList": ["10.3389/fonc.2022.869672", "35402265"]}, {"Citation": "Sharma S.; Kumar K.; Thakur N.; Chauhan S.; Chauhan M.S.; Eco-friendly Ocimum tenui\u0192lorum green route synthesis of CuO nanoparticles: Characterizations on photocatalytic and antibacterial activities. J Environ Chem Eng 2021,9(4),105395", "ArticleIdList": ["10.1016/j.jece.2021.105395"]}, {"Citation": "Piras A.; Gon\u00e7alves M.J.; Alves J.; Falconieri D.; Porcedda S.; Maxia A.; Salgueiro L.; Ocimum tenui\u0192lorum L. and Ocimum basilicum L., two spices of Lamiaceae family with bioactive essential oils. Ind Crops Prod 2018,113,89-97", "ArticleIdList": ["10.1016/j.indcrop.2018.01.024"]}, {"Citation": "Chandra M.; Kushwaha S.; Mishra B.; Sangwan N.; Molecular and structural insights for the regulation of terpenoids in Ocimum basilicum and Ocimum tenui\u0192lorum. Plant Growth Regul 2022,97(1),61-75", "ArticleIdList": ["10.1007/s10725-022-00796-y"]}, {"Citation": "Prakash P.; Gupta N.; Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: A short review. Indian J Physiol Pharmacol 2005,49(2),125-131", "ArticleIdList": ["16170979"]}, {"Citation": "Sampath Kumar K.P.; Bhowmik D.; Biswajit C.; Tripathi K.K.; Traditional indian herbal plants tulsi and its medicinal importance. J Pharmacogn Phytochem 2010,2(2),93-101"}, {"Citation": "M, S.; Kr, S.; B, S.; G, V.; S, R.; K, S.; K, M. Ocimum sanctum: A review on the pharmacological properties. Int J Basic Clin Pharmacol 2016,5(3),558-565", "ArticleIdList": ["10.18203/2319-2003.ijbcp20161491"]}, {"Citation": "Al-Khayri J.M.; Banadka A.; Nandhini M.; Nagella P.; Al-Mssallem M.Q.; Alessa F.M.; Essential Oil from Coriandrum sativum: A review on its phytochemistry and biological activity. Molecules 2023,28(2),696", "ArticleIdList": ["10.3390/molecules28020696", "36677754"]}, {"Citation": "Ka\u010d\u00e1niov\u00e1 M.; Galovi\u010dov\u00e1 L.; Ivani\u0161ov\u00e1 E.; Vukovic N.L.; \u0160tef\u00e1nikov\u00e1 J.; Valkov\u00e1 V.; Borotov\u00e1 P.; \u017diarovsk\u00e1 J.; Terentjeva M.; Fel\u0161\u00f6ciov\u00e1 S.; Tvrd\u00e1 E.; Antioxidant, antimicrobial and antibiofilm activity of coriander (Coriandrum sativum L.) essential oil for its application in foods. Foods 2020,9(3),282", "ArticleIdList": ["10.3390/foods9030282", "32143314"]}, {"Citation": "Ahmed E.H.; Abadi R.S.; Mohammed A.M.; Phytochemical screening, chemical composition and antioxidant activity of seeds essential oil of Coriandrum sativum L. from the Sudan. Int J Herb Med 2018,6(1),1-4"}, {"Citation": "Zeb A.; Coriander (Coriandrum sativum) Oils. Essential Oils in Food Preservation, Flavor and Safety 2016,359-364", "ArticleIdList": ["10.1016/B978-0-12-416641-7.00040-7"]}, {"Citation": "Pavli\u0107 B.; Vidovi\u0107 S.; Vladi\u0107 J.; Radosavljevi\u0107 R.; Zekovi\u0107 Z.; Isolation of coriander (Coriandrum sativum L.) essential oil by green extractions versus traditional techniques. J Supercrit Fluids 2015,99,23-28", "ArticleIdList": ["10.1016/j.supflu.2015.01.029"]}, {"Citation": "Sourmaghi M.H.S.; Kiaee G.; Golfakhrabadi F.; Jamalifar H.; Khanavi M.; Comparison of essential oil composition and antimicrobial activity of Coriandrum sativum L. extracted by hydrodistillation and microwave-assisted hydrodistillation. J Food Sci Technol 2015,52(4),2452-2457", "ArticleIdList": ["10.1007/s13197-014-1286-x", "25829632"]}, {"Citation": "Salem M.A.; Manaa E.G.; Osama N.; Aborehab N.M.; Ragab M.F.; Haggag Y.A.; Ibrahim M.T.; Hamdan D.I.; Coriander (Coriandrum sativum L.) essential oil and oil-loaded nano-formulations as an anti-aging potentiality via TGF\u03b2/SMAD pathway. Sci Rep 2022,12(1),6578", "ArticleIdList": ["10.1038/s41598-022-10494-4", "35449437"]}, {"Citation": "Saini N.; Grewal A.S.; Lather V.; Gahlawat S.K.; Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions. Chem Biol Interact 2022,358,109901", "ArticleIdList": ["10.1016/j.cbi.2022.109901", "35341731"]}, {"Citation": "Hasan M.R.; Alotaibi B.S.; Althafar Z.M.; Mujamammi A.H.; Jameela J.; An update on the therapeutic anticancer potential of ocimum sanctum L.: \u201cElixir of life\u201d. Molecules 2023,28(3),1193", "ArticleIdList": ["10.3390/molecules28031193", "36770859"]}, {"Citation": "Boonyanugomol W.; Rukseree K.; Prapatpong P.; Reamtong O.; Baik S.-C.; Jung M.; Shin M.-K.; Kang H.-L.; Lee W.-K.; An in vitro anti-cancer activity of ocimum tenui\u0192lorum essential oil by inducing apoptosis in human gastric cancer cell line. Medicina 2021,57(8),784", "ArticleIdList": ["10.3390/medicina57080784"]}, {"Citation": "Kumar A.; Yadav P.; Navik U.; Jaitak V.; Chemical composition, in vitro and in silico evaluation of essential oil from Eucalyptus tereticornis leaves for lung cancer. Nat Prod Res 2023,37(10),1656-1661"}, {"Citation": "Kumar A.; Gupta K.B.; Dhiman M.; Arora S.; Jaitak V.; New pentacyclic triterpene from Potentilla atrosanguinea Lodd. as anticancer agent for breast cancer targeting estrogen receptor- \u03b1. Nat Prod Res 2022,36(17),4352-4357", "ArticleIdList": ["10.1080/14786419.2021.1986495", "34606404"]}, {"Citation": "Kumar A.; Kalra S.; Jangid K.; Jaitak V.; Flavonoids as P-glycoprotein inhibitors for multidrug resistance in cancer: An in-silico approach. J Biomol Struct Dyn 2023,41(16),7627-7639", "ArticleIdList": ["10.1080/07391102.2022.2123390", "36120941"]}, {"Citation": "Aravind AP.; Kumar A.; Jangid K.; Vinod K.; Vikas J.; Structure-Structure for the identification of terpenoids as potential DPP-4 inhibitors. Curr Comput Aided Drug Des 2023"}, {"Citation": "Justus B.; Kanunfre C.C.; Budel J.M.; de Faria M.F.; Raman V.; de Paula J.P.; Farago P.V.; New insights into the mechanisms of French lavender essential oil on non-small-cell lung cancer cell growth. Ind Crops Prod 2019,136,28-36", "ArticleIdList": ["10.1016/j.indcrop.2019.04.051"]}, {"Citation": "Sharma M.; Grewal K.; Jandrotia R.; Batish D.R.; Singh H.P.; Kohli R.K.; Essential oils as anticancer agents: Potential role in malignancies, drug delivery mechanisms, and immune system enhancement. Biomed Pharmacother 2022,146,112514", "ArticleIdList": ["10.1016/j.biopha.2021.112514", "34963087"]}, {"Citation": "Odogwu L.; Mathieu L.; Goldberg K.B.; Blumenthal G.M.; Larkins E.; Fiero M.H.; Rodriguez L.; Bijwaard K.; Lee E.Y.; Philip R.; Fan I.; Donoghue M.; Keegan P.; McKee A.; Pazdur R.; FDA benefit-risk assessment of osimertinib for the treatment of metastatic non-small cell lung cancer harboring epidermal growth factor receptor T790M mutation. Oncologist 2018,23(3),353-359", "ArticleIdList": ["10.1634/theoncologist.2017-0425", "29242281"]}, {"Citation": "QikProp Available from: https://www.schrodinger.com/products/qikprop2022"}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "5", "Day": "24"}, {"Year": "2023", "Month": "7", "Day": "23"}, {"Year": "2023", "Month": "8", "Day": "3"}, {"Year": "2024", "Month": "5", "Day": "28", "Hour": "12", "Minute": "43"}, {"Year": "2023", "Month": "9", "Day": "1", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "9", "Day": "1", "Hour": "0", "Minute": "34"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37653637", "10.2174/1573409920666230831144716", "CAD-EPUB-134187"]}}], "PubmedBookArticle": []}